FDA grants priority review to Roche’s risdiplam for spinal muscular atrophy

Ads

You May Also Like

Chembio Reports Preliminary Third Quarter 2018 Revenue

Signs Definitive Agreement to Acquire opTricon GmbH MEDFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) ...

RedHill Biopharma Announces Closing of $20 Million Underwritten Offering

TEL-AVIV, Israel and RALEIGH, N.C., Dec. 11, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ...